Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01826110 · ClinicalTrials.gov registry record · Phase 1
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01826110: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT01826110 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01826110, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the radiotracer \[11C\] PIB in participants with probably Alzheimer's Disease (AD) and healthy age-matched controls.
Interventions
- DRUG [11C]PIB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-09 |
| Est. Completion | 2018-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01826110
The ClinicalTrials.gov registry entry for NCT01826110 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [11C]PIB is the first listed.
NCT01826110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01826110 about?
NCT01826110 is a clinical study titled "PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers". The purpose of this study is to investigate the radiotracer \[11C\] PIB in participants with probably Alzheimer's Disease (AD) and healthy age-matched controls.
What is the current status of trial NCT01826110?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2013-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT01826110?
The interventions under investigation include: [11C]PIB (DRUG).
Who is sponsoring clinical trial NCT01826110?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.